Genentech ยท 1 day ago
2026 Summer Intern - Translational Medicine
Genentech is a leader in biotechnology, and they are seeking a motivated and passionate intern to contribute to their translational research. The role involves generating genetically defined murine lung cancer organoid models, performing molecular characterization, and analyzing data to support translational oncology research.
BiotechnologyLife ScienceManufacturing
Responsibilities
Generate genetically defined murine lung cancer organoid models using CRISPR-based genome editing
Culture and maintain mouse tracheal epithelial organoids for cancer modeling
Engineer and validate key cancer-associated genetic alterations relevant to lung squamous cell carcinoma
Use human cancer genomics insights to guide model design and hypothesis generation
Perform molecular and phenotypic characterization of engineered organoids
Analyze data and communicate results to support translational oncology research
Qualification
Required
Must be pursuing a PhD (enrolled student)
Required majors: Cancer biology, Molecular biology, Immunology or related disciplines
Preferred
Familiarity with CRISPR/Cas9 genome editing and murine organoid culture systems is a plus
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Along with the submission of your CV, a cover letter is optional
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Recent News
2026-01-07
MarketScreener
2026-01-06
Company data provided by crunchbase